Eli Lilly & Co(CH:LLY)
CHF 1,140.00-10.00 (-0.87%)
CH:LLY
Eli Lilly & Co earnings date
CHF 1,140.00
At close:-10.00 (-0.87%)
Eli Lilly & Co (LLY) Q4 2023 Earnings Report
4 Followers
CH:LLY Q4 2023 EPS Results
- Actual EPS
- CHF 2.10
- Consensus EPS
- CHF 1.94
- Beat/Miss
- Beat by +CHF 0.16
- One Year Ago EPS
- CHF 1.76
CH:LLY Q4 2023 Revenue Results
- Actual Revenue
- CHF 7.89B
- Expected Revenue
- CHF 7.54B
- Beat/Miss
- Beat by +CHF 343.30M
- YoY Revenue Growth
- +28.10%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/06/2024
- Time
- Before Open
- Conference Call
- Tuesday, February 6, 2024
CH:LLY Upcoming Earnings
Eli Lilly & Co's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
CH:LLY Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:LLY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | 9.47- | 6.36 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 4.816.31 | 5.92 | 6.55% (+0.39) | |
| Aug 05, 2026 | 2026 (Q2) | 5.407.07 | 5.32 | 32.81% (+1.75) | |
| Apr 30, 2026 | 2026 (Q1) | 5.887.21 | 2.82 | 155.99% (+4.39) | |
| Feb 04, 2026 | 2025 (Q4) | 5.836.36 | 4.49 | 41.73% (+1.87) | |
| Oct 30, 2025 | 2025 (Q3) | 4.805.92 | 0.99 | 494.92% (+4.92) | |
| Aug 07, 2025 | 2025 (Q2) | 4.725.32 | 3.31 | 60.97% (+2.02) | |
| May 01, 2025 | 2025 (Q1) | 2.752.82 | 2.18 | 29.46% (+0.64) | |
| Feb 06, 2025 | 2024 (Q4) | 4.254.49 | 2.1 | 113.65% (+2.39) | |
| Oct 30, 2024 | 2024 (Q3) | 1.200.99 | 0.08 | 1080.00% (+0.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


